About PharmaGend
Built in Singapore for global pharmaceutical supply.
PharmaGend is a Singapore-based CDMO supporting regulated-market manufacturing, commercial supply, and lifecycle transitions for pharmaceutical partners.
About Pharmagend
Built in Singapore for global pharmaceutical supply.
PharmaGend is a Singapore-based CDMO supporting regulated-market manufacturing, commercial supply, and lifecycle transitions for pharmaceutical partners.
Who We Are
A trusted CDMO platform in Tuas Biomedical Park
PharmaGend Global Medical Services Pte Ltd operates from Tuas Biomedical Park, a Singapore cluster for global biopharmaceutical manufacturing. Our role is to help pharmaceutical companies move products through tech transfer, commercial manufacturing, quality control, and regulated-market supply with confidence.
Singapore’s reputation for integrity, efficiency, infrastructure, and regulatory discipline gives PharmaGend a strong base for serving partners across the United States, Europe, Southeast Asia, China, and other international markets.
Site land area in Tuas Biomedical Park
Building area across offices, production, and laboratories
Vision
Empowering pharma with legendary science.
Your health, our priority.
Mission
Deliver high-quality pharmaceutical solutions through collaboration, compliance, and innovation.
Values
Patient Focus
Patient Focus
Every programme begins with the health outcomes patients depend on.
Integrity
Integrity
We operate with transparency, compliance discipline, and respect for regulatory expectations.
Excellence
Excellence
We continuously strengthen systems, people, and processes for commercial manufacturing.
Our History
From Singapore site acquisition to regulated-market supply
PharmaGend acquired its Tuas site in December 2023 and started operations in early 2024. The facility resumed production in August 2024 and received US FDA approval in November 2024.
In 2025, PharmaGend received the HSA Manufacturer’s License, Swissmedic approval, and HSA GMP Certificate, creating a strong regulatory foundation for future commercial supply.
We are now commercially ready to supply regulated markets across the US, Europe, and ASEAN.
Key Milestones
Site acquired
Operations commenced; facility recommissioning and QMS established
Production resumed; first engineering batch launched
US FDA approval received
HSA Drug Manufacturing License (Singapore) received
Swissmedic approval received
GMP Certificate from HSA (Singapore) received
First commercial batch scheduled for delivery to US market
High Business Standards
Quality and compliance built into daily operations
PharmaGend’s quality approach is supported by analytical and QC laboratories, electronic management systems, data integrity practices, and inspection-ready documentation.
Operating from Singapore gives customers a trusted manufacturing base with strong infrastructure, skilled talent, and a regulatory environment known for consistency and reliability.
Our Capabilities
Commercial manufacturing across key dosage forms
PharmaGend supports oral solids today and is expanding into nasal sprays, creams and ointments, and sterile injectables. Our work connects tech transfer, development and QC, commercial manufacturing, packaging, labelling, and serialisation.